A significant breakthrough in cancer research is emerging with the use of mini-antibodies to reactivate damaged p53. This essential tumor suppressor protein is frequently inactivated in various kinds of cancer, leading https://thebookpage.com/story7445669/vhh-fragments-revive-tumor-suppressor-p53-a-new-approach-for-malignant-management